# IOL Chemicals and Pharmaceuticals (NSE: IOLCP) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/IOLCP · Pivot · prices to 22 Oct 2026

IOL Chemicals and Pharmaceuticals (NSE: IOLCP) closed at ₹173.27 on 22 Oct 2026, down 0.76% on the day. With a market capitalisation of ₹5,086 Cr, it ranks 778th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 36.9× trailing earnings, against a return on equity of 6.0% in FY25. Over the past year the share price has risen 80.5%. Its 52-week range is ₹67.19 (16 Mar 2026) to ₹224.00 (7 Oct 2026); the last close is 22.6% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹619 Cr (+17.4% year on year) and net profit ₹53 Cr (+69.2%), on a consolidated basis. Promoters held 62.28% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹173.27 |
| Market cap | ₹5,086 Cr |
| P/E (trailing) | 36.9 |
| ROE | 6.0% (FY25) |
| ROCE | 8.6% (FY25) |
| Debt to equity | 0.07 |
| 52-week high | ₹224.00 (7 Oct 2026) |
| 52-week low | ₹67.19 (16 Mar 2026) |
| 1-year return | +80.5% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹619 Cr | +17.4% | ₹53 Cr | +69.2% | ₹1.81 |
| Q3 FY26 | ₹580 Cr | +10.9% | ₹21 Cr | +0.2% | ₹0.70 |
| Q2 FY26 | ₹568 Cr | +7.9% | ₹30 Cr | +56.5% | ₹1.02 |
| Q1 FY26 | ₹552 Cr | +9.8% | ₹34 Cr | +13.2% | ₹1.16 |
| Q4 FY25 | ₹528 Cr | +4.7% | ₹31 Cr | +13.8% | ₹1.07 |
| Q3 FY25 | ₹523 Cr | +0.6% | ₹21 Cr | −11.0% | ₹3.50 |
| Q2 FY25 | ₹526 Cr | −3.6% | ₹19 Cr | −49.4% | ₹3.26 |
| Q1 FY25 | ₹502 Cr | −10.8% | ₹30 Cr | −34.6% | ₹5.11 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹2,079 Cr | ₹101 Cr |
| FY24 | ₹2,133 Cr | ₹134 Cr |
| FY23 | ₹2,217 Cr | ₹139 Cr |
| FY22 | ₹2,184 Cr | ₹168 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 62.28%
- Foreign institutions: 4.87%
- Domestic institutions: 0.43%
- Non-institutions: 32.42%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Sun Pharma Advanced Research Company](https://app.pivotnow.in/stock/SPARC) | ₹176.82 | ₹5,738 Cr | 3.7 | — |
| [Senores Pharmaceuticals](https://app.pivotnow.in/stock/SENORES) | ₹1,233.30 | ₹5,680 Cr | 46.7 | — |
| [Innova Captab](https://app.pivotnow.in/stock/INNOVACAP) | ₹983.60 | ₹5,629 Cr | 40 | — |
| [FDC](https://app.pivotnow.in/stock/FDC) | ₹339.20 | ₹5,523 Cr | — | — |
| [RPG Life Sciences](https://app.pivotnow.in/stock/RPGLIFE) | ₹2,754.80 | ₹4,556 Cr | 39.6 | — |
| [Zota Health Care](https://app.pivotnow.in/stock/ZOTA) | ₹1,304.00 | ₹4,516 Cr | — | — |

## Questions and answers

### What is the share price of IOL Chemicals and Pharmaceuticals today?

IOL Chemicals and Pharmaceuticals (NSE: IOLCP) last closed at ₹173.27 on 22 Oct 2026. Its 52-week high is ₹224.00 and its 52-week low is ₹67.19.

### What is the market cap of IOL Chemicals and Pharmaceuticals?

IOL Chemicals and Pharmaceuticals' market capitalisation is ₹5,086 Cr (₹5,086 Cr) at the 22 Oct 2026 close, ranking 778th among the NSE companies Pivot tracks.

### What is the P/E ratio of IOL Chemicals and Pharmaceuticals?

IOL Chemicals and Pharmaceuticals trades at a trailing P/E of 36.9. The median P/E of the 4 closest Pharma & Healthcare peers by market cap is 40.

### What is the ROE and ROCE of IOL Chemicals and Pharmaceuticals?

Return on equity was 6.0% in FY25 and return on capital employed was 8.6% in FY25 (consolidated figures).

### Is IOL Chemicals and Pharmaceuticals a debt-free company?

No. IOL Chemicals and Pharmaceuticals' debt-to-equity ratio was 0.07 in FY25, with total debt of ₹0 Cr.

### What were IOL Chemicals and Pharmaceuticals' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), IOL Chemicals and Pharmaceuticals reported revenue of ₹619 Cr, +17.4% year on year, and net profit of ₹53 Cr, +69.2% year on year.

### How has IOL Chemicals and Pharmaceuticals stock performed over the last year?

IOL Chemicals and Pharmaceuticals' share price has risen 80.5% over the past year, +17.1% over three months and −14.4% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of IOL Chemicals and Pharmaceuticals?

As of 30 Jun 2026: promoters 62.28%, foreign institutions 4.87%, domestic institutions 0.43%, non-institutions 32.42%.

### Who are IOL Chemicals and Pharmaceuticals' competitors?

The listed Pharma & Healthcare companies closest to IOL Chemicals and Pharmaceuticals by market cap are Sun Pharma Advanced Research Company, Senores Pharmaceuticals, Innova Captab, FDC, RPG Life Sciences and Zota Health Care.

### Is IOL Chemicals and Pharmaceuticals a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out IOL Chemicals and Pharmaceuticals' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on IOLCP against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.